Murray B. Urowitz - Publications

Affiliations: 
Medical Science University of Toronto, Toronto, ON, Canada 
Area:
Medicine and Surgery, Epidemiology

353 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, ... Urowitz MB, et al. Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis Care & Research. PMID 33152181 DOI: 10.1002/acr.24504  0.64
2020 Tselios K, Wakani L, Gladman DD, Su J, Urowitz MB. Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis. Rheumatology (Oxford, England). PMID 33140092 DOI: 10.1093/rheumatology/keaa655  0.64
2020 Almaghlouth I, Pullenayegum E, Gladman DD, Urowitz MB, Johnson SR. Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 32611674 DOI: 10.3899/jrheum.200254  0.64
2020 Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32515554 DOI: 10.1002/art.41392  0.64
2020 Petri M, Goldman DW, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace D, Nived O, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, ... ... Urowitz M, et al. A Comparison of 2019 EULAR/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria. Arthritis Care & Research. PMID 32433832 DOI: 10.1002/acr.24263  0.4
2020 Touma Z, Gladman DD, Zandy M, Su J, Anderson N, Urowitz MB. Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG). Arthritis Care & Research. PMID 32433815 DOI: 10.1002/acr.24261  1
2020 Tselios K, Gladman DD, Su J, Urowitz MB. Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable? The Journal of Rheumatology. PMID 32238519 DOI: 10.3899/jrheum.191064  0.64
2020 Urowitz MB, Gladman DD, Ibañez D, Su J, Mursleen S, Sayani A, Alfonso J, Terres R, Iczkovitz S. Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort. The Journal of Rheumatology. PMID 32238510 DOI: 10.3899/jrheum.190259  0.64
2020 Tselios K, Gladman DD, Su J, Urowitz M. Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 32156706 DOI: 10.1136/annrheumdis-2019-216764  0.56
2020 Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, et al. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. Annals of the Rheumatic Diseases. PMID 31915121 DOI: 10.1136/annrheumdis-2019-216150  0.64
2019 Hanneman K, Alberdi HV, Karur GR, Tselios K, Harvey PJ, Gladman DD, Akhtari S, Osuntokun T, Wald RM, Thavendiranathan P, Butany J, Urowitz MB. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI. Jacc. Cardiovascular Imaging. PMID 31734202 DOI: 10.1016/j.jcmg.2019.09.014  0.64
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, ... Urowitz MB, et al. Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis & Rheumatology (Hoboken, N.J.). PMID 31631584 DOI: 10.1002/art.41144  0.64
2019 Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus. Journal of Autoimmunity. 102340. PMID 31629628 DOI: 10.1016/j.jaut.2019.102340  0.64
2019 Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach. Arthritis Care & Research. PMID 31609532 DOI: 10.1002/acr.24092  0.64
2019 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, et al. Peripheral nervous system disease in Systemic Lupus Erythematosus: Results from an international, inception cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31390162 DOI: 10.1002/art.41070  0.64
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31385462 DOI: 10.1002/art.40930  1
2019 Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, ... ... Urowitz M, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases. PMID 31383717 DOI: 10.1136/annrheumdis-2018-214819  1
2019 Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Dr. Tselios, , reply. The Journal of Rheumatology. PMID 31263072 DOI: 10.3899/jrheum.190255  0.64
2019 Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, Paterson AD, Touma Z, Urowitz MB, Wither JE, Silverman ED, Hiraki LT. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology (Oxford, England). PMID 31236574 DOI: 10.1093/rheumatology/kez220  1
2019 Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Annals of the Rheumatic Diseases. PMID 30992296 DOI: 10.1136/annrheumdis-2018-214802  0.56
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, ... Urowitz MB, et al. Construction of a frailty index as a novel health measure in systemic lupus erythematosus. The Journal of Rheumatology. PMID 30988130 DOI: 10.3899/jrheum.181338  0.64
2019 Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, ... Urowitz MB, et al. Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30771242 DOI: 10.1002/art.40859  0.64
2019 Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, et al. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford, England). PMID 30753683 DOI: 10.1093/rheumatology/kez014  0.64
2019 Urowitz MB, Su J, Gladman DD. Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story. The Journal of Rheumatology. PMID 30709950 DOI: 10.3899/jrheum.180986  0.64
2019 Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, et al. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort. The Journal of Rheumatology. PMID 30647177 DOI: 10.3899/jrheum.180713  0.64
2018 Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Annals of the Rheumatic Diseases. PMID 30573656 DOI: 10.1136/annrheumdis-2018-214434  0.64
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Disease course patterns in systemic lupus erythematosus. Lupus. 961203318817132. PMID 30526328 DOI: 10.1177/0961203318817132  1
2018 Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Correction to: Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 30430267 DOI: 10.1007/s10067-018-4363-0  0.64
2018 Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Seminars in Arthritis and Rheumatism. PMID 30415943 DOI: 10.1016/j.semarthrit.2018.10.013  0.64
2018 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, et al. Psychosis in Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30375754 DOI: 10.1002/art.40764  0.64
2018 Tselios K, Deeb M, Gladman DD, Harvey P, Akhtari S, Mak S, Butany J, Urowitz MB. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered? The Journal of Rheumatology. PMID 30323009 DOI: 10.3899/jrheum.180124  0.64
2018 Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, ... ... Urowitz M, et al. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 30173152 DOI: 10.3899/jrheum.171459  1
2018 Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials? The Journal of Rheumatology. PMID 30068764 DOI: 10.3899/jrheum.171436  0.64
2018 Keeling SO, Bissonauth A, Bernatsky S, Vandermeer B, Fortin PR, Gladman DD, Peschken C, Urowitz MB. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada. The Journal of Rheumatology. PMID 30068762 DOI: 10.3899/jrheum.171307  0.64
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Clinical remission and low disease activity have comparable outcomes over 10 years in systemic lupus erythematosus. Arthritis Care & Research. PMID 30055090 DOI: 10.1002/acr.23720  1
2018 Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care & Research. PMID 30044551 DOI: 10.1002/acr.23712  0.64
2018 Tselios K, Gladman DD, Touma Z, Su J, Anderson N, Urowitz MB. Monophasic Disease Course in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29858240 DOI: 10.3899/jrheum.171319  1
2018 Touma Z, Gladman DD, Su J, Anderson N, Urowitz MB. A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index. Rheumatology (Oxford, England). PMID 29688532 DOI: 10.1093/rheumatology/key103  1
2018 Tselios K, Gladman DD, Harvey P, Su J, Urowitz MB. Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus. 961203318770526. PMID 29665757 DOI: 10.1177/0961203318770526  0.64
2018 Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB. Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus. 961203318770018. PMID 29642752 DOI: 10.1177/0961203318770018  0.64
2018 Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, et al. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford, England). PMID 29361147 DOI: 10.1093/rheumatology/kex444  0.64
2018 Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PR, Yelin EH, Ginzler E, Hanly JG, Peschken C, Gordon C, Nived O, Aranow C, Bae SC, Isenberg D, et al. Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29335347 DOI: 10.3899/jrheum.170652  0.64
2018 Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, et al. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care & Research. PMID 29316357 DOI: 10.1002/acr.23509  0.64
2017 Ferreira I, Croca S, Raimondo MG, Matharu M, Miller S, Giles I, Isenberg D, Ioannou Y, Hanly JG, Urowitz MB, Anderson N, Aranow C, Askanase A, Bae SC, Bernatsky S, et al. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study. Arthritis Research & Therapy. 19: 287. PMID 29273092 DOI: 10.1186/s13075-017-1495-6  0.64
2017 Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, et al. Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach. Arthritis Care & Research. PMID 29193883 DOI: 10.1002/acr.23480  0.64
2017 Pakchotanon R, Gladman DD, Su J, Urowitz MB. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 29142038 DOI: 10.3899/jrheum.170645  0.64
2017 Tselios K, Gladman DD, Su J, Ace O, Urowitz MB. Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study. The Journal of Rheumatology. PMID 29093154 DOI: 10.3899/jrheum.161121  0.64
2017 Tselios K, Lam WC, Urowitz MB, Gladman DD. Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. PMID 29059086 DOI: 10.1097/RHU.0000000000000600  0.64
2017 Pakchotanon R, Gladman DD, Su J, Urowitz MB. Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis. Lupus. 961203317726376. PMID 28857717 DOI: 10.1177/0961203317726376  0.64
2017 Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB. Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus. 961203317722411. PMID 28758573 DOI: 10.1177/0961203317722411  0.64
2017 Urowitz MB, Gladman DD. Reply. Arthritis Care & Research. PMID 28686813 DOI: 10.1002/acr.23309  0.64
2017 Gu K, Gladman DD, Su J, Urowitz MB. Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center. The Journal of Rheumatology. PMID 28620060 DOI: 10.3899/jrheum.170072  0.64
2017 Chan K, Clarke AE, Ramsey-Goldman R, Foulkes W, Tessier Cloutier B, Urowitz MB, Gladman D, Nived O, Romero-Diaz J, Petri M, Ginzler E, Fortin PR, Bae SC, Wallace DJ, Yelin EH, et al. Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment. Lupus. 961203317713146. PMID 28595511 DOI: 10.1177/0961203317713146  0.64
2017 Aljohani R, Gladman DD, Su J, Urowitz MB. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics. Clinical Rheumatology. PMID 28589322 DOI: 10.1007/s10067-017-3713-7  0.64
2017 Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus. 961203317711012. PMID 28530464 DOI: 10.1177/0961203317711012  0.64
2017 Aljohani R, Gladman DD, Su J, Urowitz MB. Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus. 961203317696593. PMID 28420066 DOI: 10.1177/0961203317696593  0.64
2017 Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, et al. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. Lupus. 961203317692437. PMID 28420054 DOI: 10.1177/0961203317692437  0.64
2017 Al Rayes H, Harvey PJ, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. Arthritis Research & Therapy. 19: 31. PMID 28183339 DOI: 10.1186/s13075-017-1240-1  1
2017 Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 28168661 DOI: 10.1007/s10067-017-3566-0  0.64
2017 Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatology : Research and Reviews. 9: 1-9. PMID 28053559 DOI: 10.2147/OARRR.S123549  0.64
2016 Yap KS, Urowitz MB, Mahood Q, Medina-Rosas J, Sabapathy A, Lawson D, Su J, Gladman DD, Touma Z. The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: Systematic literature review and analysis of the Toronto lupus cohort. Seminars in Arthritis and Rheumatism. PMID 27769590 DOI: 10.1016/j.semarthrit.2016.09.008  1
2016 Polachek A, Gladman DD, Su J, Urowitz MB. Defining low disease activity in systemic lupus erythematosus. Arthritis Care & Research. PMID 27696791 DOI: 10.1002/acr.23109  0.64
2016 Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PF, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, Hanly JG, Gordon C, Nived O, Yelin EH, Isenberg D, et al. Breast cancer in systemic lupus. Lupus. PMID 27687028 DOI: 10.1177/0961203316664595  0.64
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Dr. Tselios, et al reply. The Journal of Rheumatology. 43: 1767. PMID 27587017 DOI: 10.3899/jrheum.160749  1
2016 Cramarossa G, Urowitz MB, Su J, Gladman D, Touma Z. Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus. Lupus. PMID 27522094 DOI: 10.1177/0961203316664597  1
2016 Miloslavsky EM, Naden RP, Bijlsma JW, Brogan PA, Brown ES, Brunetta P, Buttgereit F, Choi HK, DiCaire JF, Gelfand JM, Heaney LG, Lightstone L, Lu N, Murrell DF, Petri M, ... ... Urowitz MB, et al. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis. Annals of the Rheumatic Diseases. PMID 27474764 DOI: 10.1136/annrheumdis-2016-210002  1
2016 Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB. Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. 22: 287-8. PMID 27464781 DOI: 10.1097/RHU.0000000000000400  0.64
2016 Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G. Systemic lupus erythematosus. Nature Reviews. Disease Primers. 2: 16039. PMID 27306639 DOI: 10.1038/nrdp.2016.39  1
2016 Sheane BJ, Gladman DD, Su J, Urowitz MB. Disease outcomes in corticosteroid-naïve patients with systemic lupus erythematosus. Arthritis Care & Research. PMID 27214378 DOI: 10.1002/acr.22938  0.64
2016 Urowitz MB, Gladman DD, Anderson NM, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke A, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort. Lupus Science & Medicine. 3: e000143. PMID 27099765 DOI: 10.1136/lupus-2015-000143  0.56
2016 Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, et al. A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26991067 DOI: 10.1002/art.39674  1
2016 Urowitz MB, Ibañez D, Su J, Gladman DD. Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus. The Journal of Rheumatology. PMID 26879352 DOI: 10.3899/jrheum.150983  1
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Does renin-angiotensin system blockade protect lupus nephritis patients from atherosclerotic cardiovascular events? A case-control study. Arthritis Care & Research. PMID 26866934 DOI: 10.1002/acr.22857  1
2016 Tselios K, Gladman DD, Su J, Urowitz MB. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. The Journal of Rheumatology. PMID 26773121 DOI: 10.3899/jrheum.150779  1
2016 Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. The Journal of Rheumatology. 43: 54-65. PMID 26568591 DOI: 10.3899/jrheum.150460  0.64
2016 Touma Z, Urowitz MB. Systemic Glucocorticoids Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. 521-531. DOI: 10.1016/B978-0-12-801917-7.00061-9  1
2015 Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity? Seminars in Arthritis and Rheumatism. PMID 26711309 DOI: 10.1016/j.semarthrit.2015.10.010  1
2015 Tselios K, Gladman DD, Su J, Urowitz MB. Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus. Lupus. PMID 26585070 DOI: 10.1177/0961203315617845  1
2015 Steiman AJ, Gladman DD, Ibañez D, Noamani B, Landolt-Marticorena C, Urowitz MB, Wither JE. Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 2318-26. PMID 26568589 DOI: 10.3899/jrheum.150040  1
2015 Medina-Rosas J, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus. Arthritis Research & Therapy. 17: 296. PMID 26497948 DOI: 10.1186/s13075-015-0808-x  1
2015 Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford, England). PMID 26342222 DOI: 10.1093/rheumatology/kev311  1
2015 Isenberg DA, Petri M, Kalunian K, Tanaka Y, Urowitz MB, Hoffman RW, Morgan-Cox M, Iikuni N, Silk M, Wallace DJ. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases. PMID 26338095 DOI: 10.1136/annrheumdis-2015-207653  1
2015 Urowitz MB, Isenberg DA, Wallace DJ. Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study. Lupus Science & Medicine. 2: e000104. PMID 26301100 DOI: 10.1136/lupus-2015-000104  1
2015 Touma Z, Gladman DD, Su J, Ibañez D, Urowitz MB. SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement. The Journal of Rheumatology. 42: 1401-5. PMID 26077403 DOI: 10.3899/jrheum.141088  1
2015 Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, et al. Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1837-47. PMID 25778456 DOI: 10.1002/art.39111  1
2015 Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. The Journal of Rheumatology. 42: 810-6. PMID 25729033 DOI: 10.3899/jrheum.140796  1
2015 Chang NH, Li TT, Kim JJ, Landolt-Marticorena C, Fortin PR, Gladman DD, Urowitz MB, Wither JE. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus. Journal of Autoimmunity. 58: 100-10. PMID 25678471 DOI: 10.1016/j.jaut.2015.01.009  1
2015 Ding JY, Ibañez D, Gladman DD, Urowitz MB. Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity. The Journal of Rheumatology. 42: 437-40. PMID 25593226 DOI: 10.3899/jrheum.140415  1
2015 Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, Urowitz M, Scholey J, Fortin PR, Boutros PC, Wither J, Landolt-Marticorena C. Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus. Rheumatology (Oxford, England). 54: 449-57. PMID 25193804 DOI: 10.1093/rheumatology/keu326  1
2015 Clarke AE, Urowitz MB, Monga N, Hanly JG. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada. Arthritis Care & Research. 67: 431-6. PMID 25185936 DOI: 10.1002/acr.22452  1
2015 Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, ... ... Urowitz MB, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus. 24: 42-9. PMID 25124676 DOI: 10.1177/0961203314547791  1
2015 Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, et al. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care & Research. 67: 128-35. PMID 24838943 DOI: 10.1002/acr.22370  1
2015 Parker B, Urowitz MB, Gladman DD, Lunt M, Donn R, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, et al. Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 74: 1530-6. PMID 24692585 DOI: 10.1136/annrheumdis-2013-203933  1
2015 Haddad A, Gladman DD, Ibañez D, Urowitz MB. Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia Lupus. 24: 822-826. DOI: 10.1177/0961203314565689  1
2014 Steiman AJ, Urowitz MB, Ibañez D, Papneja A, Gladman DD. Prolonged clinical remission in patients with systemic lupus erythematosus. The Journal of Rheumatology. 41: 1808-16. PMID 25086082 DOI: 10.3899/jrheum.131137  0.64
2014 Eder L, Gladman DD, Ibañez D, Urowitz MB. The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 23: 1142-8. PMID 24876099 DOI: 10.1177/0961203314537696  1
2014 Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, ... ... Urowitz MB, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the Rheumatic Diseases. PMID 24834926 DOI: 10.1136/annrheumdis-2013-205171  1
2014 Al Maimouni H, Gladman DD, Ibañez D, Urowitz MB. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care & Research. 66: 1905-9. PMID 24821661 DOI: 10.1002/acr.22364  1
2014 Urowitz MB, Gladman DD, Ibañez D, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Bae SC, Clarke AE, Bernatsky S, Fortin PR, Hanly JG, Isenberg D, Rahman A, Wallace DJ, Ginzler E, et al. American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort. The Journal of Rheumatology. 41: 875-80. PMID 24692526 DOI: 10.3899/jrheum.130704  1
2014 Urowitz M, Gladman DD, Ibañez D, Sanchez-Guerrero J, Bae SC, Gordon C, Fortin PR, Clarke A, Bernatsky S, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Merrill J, Ginzler E, et al. Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care & Research. 66: 1374-9. PMID 24497416 DOI: 10.1002/acr.22299  1
2014 Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care & Research. 66: 1167-76. PMID 24470118 DOI: 10.1002/acr.22291  1
2014 Touma Z, Urowitz MB, Ibañez D, Gladman DD. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. The Journal of Rheumatology. 41: 688-97. PMID 24429170 DOI: 10.3899/jrheum.130005  1
2014 Tselios K, Koumaras C, Urowitz MB, Gladman DD. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal. Seminars in Arthritis and Rheumatism. 43: 521-5. PMID 23953498 DOI: 10.1016/j.semarthrit.2013.07.007  1
2014 Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Annals of the Rheumatic Diseases. 73: 138-42. PMID 23303389 DOI: 10.1136/annrheumdis-2012-202099  1
2013 Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Clarke AE, Bernatsky S, Wallace DJ, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Petri M, et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis and Rheumatism. 65: 2887-97. PMID 24166793 DOI: 10.1002/art.38106  1
2013 Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus. The Journal of Rheumatology. 40: 2006-14. PMID 24128779 DOI: 10.3899/jrheum.121273  1
2013 Lu M, Bernatsky S, Ramsey-Goldman R, Petri M, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler EM, Yelin E, Bae SC, Wallace DJ, Jacobsen S, Dooley MA, Peschken CA, et al. Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology. 85: 235-40. PMID 24107608 DOI: 10.1159/000350165  1
2013 Nikpour M, Gladman DD, Urowitz MB. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus. 22: 1243-50. PMID 24097996 DOI: 10.1177/0961203313493031  1
2013 Eder L, Urowitz MB, Gladman DD. Damage in lupus patients--what have we learned so far? Lupus. 22: 1225-31. PMID 24097994 DOI: 10.1177/0961203313492872  1
2013 Tessier Cloutier B, Clarke AE, Ramsey-Goldman R, Wang Y, Foulkes W, Gordon C, Hansen JE, Yelin E, Urowitz MB, Gladman D, Fortin PR, Wallace DJ, Petri M, Manzi S, Ginzler EM, et al. Breast cancer in systemic lupus erythematosus. Oncology. 85: 117-21. PMID 23887245 DOI: 10.1159/000353138  1
2013 Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 733. PMID 23637378 DOI: 10.3899/jrheum.130030  1
2013 Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. The Journal of Rheumatology. 40: 831-41. PMID 23588942 DOI: 10.3899/jrheum.120572  1
2013 Urowitz MB, Gordon D, Goldsmith CH, Wolfe F. In memoriam - Hugh A. Smythe, 1927-2012. The Journal of Rheumatology. 40: 343-7. PMID 23547251 DOI: 10.3899/jrheum.121357  1
2013 Gladman DD, Ibañez D, Ruiz I, Urowitz MB. Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. The Journal of Rheumatology. 40: 630-3. PMID 23457385 DOI: 10.3899/jrheum.121094  1
2013 Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. Journal of Autoimmunity. 42: 130-5. PMID 23410586 DOI: 10.1016/j.jaut.2012.12.009  1
2013 Touma Z, Gladman DD, Urowitz MB. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Current Opinion in Rheumatology. 25: 164-70. PMID 23370371 DOI: 10.1097/BOR.0b013e32835d2b7b  1
2013 Touma Z, Urowitz MB, Gladman DD. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opinion On Biological Therapy. 13: 723-37. PMID 23339281 DOI: 10.1517/14712598.2013.764411  1
2013 Touma Z, Haddad A, Gladman DD, Uleryk EM, Urowitz MB. Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis. Seminars in Arthritis and Rheumatism. 42: 498-506. PMID 23332736 DOI: 10.1016/j.semarthrit.2012.08.002  1
2013 Venner AA, Ibañez D, Gladman DD, Urowitz MB, MacKinnon A, Blasutig IM, Yip PM. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity. Clinical Biochemistry. 46: 317-20. PMID 23246539 DOI: 10.1016/j.clinbiochem.2012.12.004  1
2013 Touma Z, Gladman DD, MacKinnon A, Carette S, Abu-Shakra M, Askanase A, Nived O, Hanly JG, Landolt-Marticorena C, Tam LS, Toloza S, Nikpour M, Riddell C, Steiman A, Eder L, ... ... Urowitz MB, et al. Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 34-9. PMID 23118108 DOI: 10.3899/jrheum.120754  1
2013 Parker B, Urowitz MB, Gladman DD, Lunt M, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, et al. Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Annals of the Rheumatic Diseases. 72: 1308-14. PMID 22945501 DOI: 10.1136/annrheumdis-2012-202106  1
2013 Touma Z, Urowitz MB, Gladman DD. Outcome measures in systemic lupus erythematosus Indian Journal of Rheumatology. 8. DOI: 10.1016/j.injr.2013.11.015  1
2012 Takahashi SG, Rothman A, Nayer M, Urowitz MB, Crescenzi AM. Validation of a large-scale clinical examination for international medical graduates. Canadian Family Physician MéDecin De Famille Canadien. 58: e408-17. PMID 22859643  1
2012 Touma Z, Gladman DD, Ibañez D, Urowitz MB. SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years. Lupus. 21: 1305-11. PMID 22800940 DOI: 10.1177/0961203312454344  1
2012 Touma Z, Urowitz MB, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Rheumatology (Oxford, England). 51: 1814-9. PMID 22718868 DOI: 10.1093/rheumatology/kes146  1
2012 Nikpour M, Harvey PJ, Ibanez D, Gladman DD, Urowitz MB. High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus. Arthritis and Rheumatism. 64: 3052-3. PMID 22614710 DOI: 10.1002/art.34541  1
2012 Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Seminars in Arthritis and Rheumatism. 42: 179-85. PMID 22595642 DOI: 10.1016/j.semarthrit.2012.03.011  1
2012 Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, ... ... Urowitz M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism. 64: 2677-86. PMID 22553077 DOI: 10.1002/art.34473  1
2012 Gladman DD, Urowitz MB. University of Toronto Lupus Clinic turns 40. The Journal of Rheumatology. 39: 1074-7. PMID 22550007 DOI: 10.3899/jrheum.111581  1
2012 Hanly JG, Urowitz MB, Su L, Gordon C, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Wallace DJ, Clarke AE, Ginzler E, Merrill JT, Isenberg DA, Rahman A, Petri M, Fortin PR, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Annals of the Rheumatic Diseases. 71: 1502-9. PMID 22492779 DOI: 10.1136/annrheumdis-2011-201089  1
2012 Wang M, Gladman DD, Ibañez D, Urowitz MB. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care & Research. 64: 833-7. PMID 22290935 DOI: 10.1002/acr.21624  1
2012 Huang D, Aghdassi E, Su J, Mosko J, Hirschfield GM, Gladman DD, Urowitz MB, Fortin PR. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 39: 254-61. PMID 22174205 DOI: 10.3899/jrheum.110310  1
2012 Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period. Arthritis Care & Research. 64: 511-8. PMID 22162433 DOI: 10.1002/acr.21568  1
2012 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. Rheumatology (Oxford, England). 51: 528-34. PMID 22120460 DOI: 10.1093/rheumatology/ker339  1
2012 Touma Z, Gladman DD, Urowitz MB. Clinical Measures, Metrics, and Indices Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition. 563-581. DOI: 10.1016/B978-1-4377-1893-5.00046-7  1
2011 Urowitz MB, Anton A, Ibanez D, Gladman DD. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care & Research. 63: 1517-20. PMID 22034113 DOI: 10.1002/acr.20599  1
2011 Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Research & Therapy. 13: R156. PMID 21955652 DOI: 10.1186/ar3473  1
2011 Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Wallace DJ, Fortin PR, Gladman D, Romero-Diaz J, Romero-Dirz J, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1726-32. PMID 21893582 DOI: 10.1136/ard.2010.148502  1
2011 Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. The Journal of Rheumatology. 38: 2395-9. PMID 21885488 DOI: 10.3899/jrheum.110550  1
2011 Barber CE, Leclerc R, Gladman DD, Urowitz MB, Fortin PR. Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 353-63. PMID 21868061 DOI: 10.1016/j.semarthrit.2011.07.001  1
2011 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? The Journal of Rheumatology. 38: 1898-905. PMID 21724700 DOI: 10.3899/jrheum.110007  1
2011 Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 41: 203-11. PMID 21641018 DOI: 10.1016/j.semarthrit.2011.04.001  0.64
2011 Aghdassi E, Ma DW, Morrison S, Hillyer LM, Clarke S, Gladman DD, Urowitz MB, Fortin PR. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. Jpen. Journal of Parenteral and Enteral Nutrition. 35: 198-208. PMID 21378249 DOI: 10.1177/0148607110386378  0.64
2011 Balitsky AK, Peeva V, Su J, Aghdassi E, Yeo E, Gladman DD, Urowitz MB, Fortin PR. Thrombovascular events affect quality of life in patients with systemic lupus erythematosus. The Journal of Rheumatology. 38: 1017-9. PMID 21362766 DOI: 10.3899/jrheum.101054  0.64
2011 Ippolito A, Wallace DJ, Gladman D, Fortin PR, Urowitz M, Werth V, Costner M, Gordon C, Alarcón GS, Ramsey-Goldman R, Maddison P, Clarke A, Bernatsky S, Manzi S, Bae SC, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 20: 250-5. PMID 21362750 DOI: 10.1177/0961203310385738  1
2011 Hanly JG, Urowitz MB, Jackson D, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Fortin PR, et al. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 961-7. PMID 21342917 DOI: 10.1136/ard.2010.138792  1
2011 Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. The Journal of Rheumatology. 38: 868-73. PMID 21324961 DOI: 10.3899/jrheum.101080  1
2011 Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR. Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus. Kidney International. 79: 914-20. PMID 21248713 DOI: 10.1038/ki.2010.525  1
2011 Landolt-Marticorena C, Wither R, Reich H, Herzenberg A, Scholey J, Gladman DD, Urowitz MB, Fortin PR, Wither J. Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus. The Journal of Rheumatology. 38: 642-51. PMID 21239754 DOI: 10.3899/jrheum.100214  1
2011 Touma Z, Urowitz MB, Ibañez D, Gladman DD. SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus. 20: 67-70. PMID 21233149 DOI: 10.1177/0961203310385163  1
2011 Zhang W, Aghdassi E, Reich HN, Su J, Lou W, Landolt-Marticorena C, Gladman DD, Urowitz MB, Scholey J, Fortin PR. Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosus. Rheumatology (Oxford, England). 50: 799-805. PMID 21156670 DOI: 10.1093/rheumatology/keq383  1
2011 Touma Z, Gladman DD, Ibañez D, Urowitz MB. Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50. The Journal of Rheumatology. 38: 275-84. PMID 21123323 DOI: 10.3899/jrheum.100724  1
2011 Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus. 20: 299-304. PMID 21078763 DOI: 10.1177/0961203310381512  1
2011 Bernatsky S, Peschken C, Fortin PR, Pineau CA, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE. Medication use in systemic lupus erythematosus. The Journal of Rheumatology. 38: 271-4. PMID 21078722 DOI: 10.3899/jrheum.100414  0.64
2011 Ibañez D, Gladman DD, Touma Z, Nikpour M, Urowitz MB. Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time. The Journal of Rheumatology. 38: 60-3. PMID 21078718 DOI: 10.3899/jrheum.100575  1
2011 Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS. Mycophenolate mofetil for induction treatment of lupus nephritis: A systematic review and metaanalysis Journal of Rheumatology. 38: 69-78. PMID 20952473 DOI: 10.3899/jrheum.100130  1
2011 Hanly JG, Urowitz MB, Su L, Romero-Diaz J. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus (Annals of the Rheumatic Diseases (2011) 70, (1726-1732)) Annals of the Rheumatic Diseases. 70: 2240. DOI: 10.1136/ard.2010.148502corr1  1
2010 Touma Z, Gladman DD, Tulloch-Reid D, Toloza SM, Ibañez D, Fortin PR, Urowitz MB. Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus. Clinical and Experimental Rheumatology. 28: 525-31. PMID 20659409  1
2010 Steiman AJ, Gladman DD, Ibañez D, Urowitz MB. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome. The Journal of Rheumatology. 37: 1822-7. PMID 20595281 DOI: 10.3899/jrheum.100007  1
2010 Nikpour M, Gladman DD, Ibanez D, Harvey PJ, Urowitz MB. Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study. Arthritis Research & Therapy. 12: R125. PMID 20591138 DOI: 10.1186/ar3063  1
2010 Urowitz MB, Gladman D, Ibañez D, Bae SC, Sanchez-Guerrero J, Gordon C, Clarke A, Bernatsky S, Fortin PR, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Alarcón GS, Merrill JT, et al. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care & Research. 62: 881-7. PMID 20535799 DOI: 10.1002/acr.20122  1
2010 Zhu LJ, Landolt-Marticorena C, Li T, Yang X, Yu XQ, Gladman DD, Urowitz MB, Fortin PR, Wither JE. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus. The Journal of Rheumatology. 37: 1658-66. PMID 20516030 DOI: 10.3899/jrheum.091123  1
2010 Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, Scholey J, Gladman DD, Urowitz MB, Fortin PR. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 1667-72. PMID 20516026 DOI: 10.3899/jrheum.091028  1
2010 Gladman DD, Tandon A, Ibañez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. The Journal of Rheumatology. 37: 754-8. PMID 20231194 DOI: 10.3899/jrheum.090872  1
2010 Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, Lou W, Fortin PR. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis and Rheumatism. 62: 863-8. PMID 20131232 DOI: 10.1002/art.27289  0.56
2010 Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, et al. Clinical and serologic factors associated with lupus pleuritis. The Journal of Rheumatology. 37: 747-53. PMID 20110526 DOI: 10.3899/jrheum.090249  1
2010 Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau CA, Gladman D, Urowitz M, Pope J, Peschken C, Dacosta D, Wither J, Fortin PR. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 87-90. PMID 19955051 DOI: 10.3899/jrheum.090761  1
2010 Touma Z, Urowitz MB, Gladman DD. SLEDAI-2K for a 30-day window. Lupus. 19: 49-51. PMID 19910390 DOI: 10.1177/0961203309346505  1
2010 Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus. 19: 13-9. PMID 19897520 DOI: 10.1177/0961203309345775  0.64
2010 Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcón GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 69: 529-35. PMID 19359262 DOI: 10.1136/ard.2008.106351  1
2010 Gladman DG, Urowitz MB. Reply Arthritis Care and Research. 62: 581. DOI: 10.1002/acr.20056  1
2009 Goldberg RJ, Urowitz MB, Ibañez D, Nikpour M, Gladman DD. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. The Journal of Rheumatology. 36: 2454-61. PMID 19833754 DOI: 10.3899/jrheum.090011  1
2009 Nikpour M, Gladman DD, Ibañez D, Urowitz MB. Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus. 18: 966-73. PMID 19762397 DOI: 10.1177/0961203309105130  1
2009 Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis and Rheumatism. 61: 1152-8. PMID 19714602 DOI: 10.1002/art.24741  1
2009 Nikpour M, Urowitz MB, Gladman DD. Epidemiology of atherosclerosis in systemic lupus erythematosus. Current Rheumatology Reports. 11: 248-54. PMID 19691927 DOI: 10.1007/s11926-009-0035-z  1
2009 Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort. The Journal of Rheumatology. 36: 1200-8. PMID 19369456 DOI: 10.3899/jrheum.080912  1
2009 Hochman J, Urowitz MB, Ibañz D, Gladman DD. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease Lupus. 18: 313-317. PMID 19276299 DOI: 10.1177/0961203308097475  1
2009 Nikpour M, Gladman DD, Ibañez D, Bruce IN, Burns RJ, Urowitz MB. Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus. The Journal of Rheumatology. 36: 288-94. PMID 19208561 DOI: 10.3899/jrheum.080776  1
2009 Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Seminars in Arthritis and Rheumatism. 38: 372-81. PMID 18395771 DOI: 10.1016/j.semarthrit.2008.01.015  1
2008 Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. The Journal of Rheumatology. 35: 2152-8. PMID 18793004 DOI: 10.3899/jrheum.080214  0.64
2008 Urowitz MB, Gladman DD. The SLICC inception cohort for atherosclerosis. Current Rheumatology Reports. 10: 281-5. PMID 18662507 DOI: 10.1007/s11926-008-0045-2  1
2008 Urowitz MB, Gladman DD, MacKinnon A, Ibañez D, Bruto V, Rovet J, Silverman E. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus. 17: 555-60. PMID 18539709 DOI: 10.1177/0961203308089326  0.64
2008 Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, ... ... Urowitz MB, et al. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis and Rheumatism. 58: 1784-8. PMID 18512819 DOI: 10.1002/art.23456  1
2008 Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcón GS, Adu D, Avila-Casado C, Bernatsky SR, ... ... Urowitz MB, et al. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis and Rheumatism. 58: 1789-95. PMID 18512814 DOI: 10.1002/art.23802  1
2008 Orlacchio A, Bruce IN, Rahman P, Kawarai T, Bernardi G, St George-Hyslop PH, Gladman DD, Urowitz MB. The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 14: CR233-237. PMID 18443545  1
2008 Hanly JG, Urowitz MB, Su L, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Merrill JT, Clarke A, Bernatsky S, Dooley MA, Fortin PR, Gladman D, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis and Rheumatism. 59: 721-9. PMID 18438902 DOI: 10.1002/art.23566  1
2008 Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis and Rheumatism. 58: 843-53. PMID 18311802 DOI: 10.1002/art.23218  0.4
2008 Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcón GS, et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis and Rheumatism. 59: 176-80. PMID 18240193 DOI: 10.1002/art.23353  0.64
2008 Kuriya B, Gladman DD, Ibañez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis and Rheumatism. 59: 181-5. PMID 18240183 DOI: 10.1002/art.23339  1
2008 Chang NH, McKenzie T, Bonventi G, Landolt-Marticorena C, Fortin PR, Gladman D, Urowitz M, Wither JE. Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 180: 1276-84. PMID 18178868 DOI: 10.4049/jimmunol.180.2.1276  1
2008 Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Annals of the Rheumatic Diseases. 67: 1069-75. PMID 18063674 DOI: 10.1136/ard.2007.074765  1
2008 Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, et al. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Annals of the Rheumatic Diseases. 67: 74-9. PMID 17545189 DOI: 10.1136/ard.2006.069039  0.4
2007 Urowitz MB, Gladman DD. Atherosclerosis and lupus - The SLICC study Lupus. 16: 925-928. PMID 18042585 DOI: 10.1177/0961203307085259  1
2007 Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcon G, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 16: 731-5. PMID 17728367 DOI: 10.1177/0961203307081113  0.64
2007 Toloza S, Urowitz MB, Gladman DD. Should all patients with systemic lupus erythematosus receive cardioprotection with statins? Nature Clinical Practice. Rheumatology. 3: 536-7. PMID 17700557 DOI: 10.1038/ncprheum0593  1
2007 Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus. 16: 426-9. PMID 17664233 DOI: 10.1177/0961203307079045  1
2007 Urowitz MB, Ibañez D, Ali Y, Gladman DD. Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide. The Journal of Rheumatology. 34: 1491-6. PMID 17610320  1
2007 Prasad R, Ibanez D, Gladman D, Urowitz MB. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: A nested case-control study of inception patients Lupus. 16: 157-162. PMID 17432099 DOI: 10.1177/0961203306075771  1
2007 Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Clarke A, Bernatsky S, Merrill JT, Petri M, Dooley MA, Gladman D, Fortin PR, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis and Rheumatism. 56: 265-73. PMID 17195230 DOI: 10.1002/art.22305  0.4
2007 Urowitz MB, Ibañez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. The Journal of Rheumatology. 34: 70-5. PMID 17117488  0.64
2007 Urowitz MB. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with SLE Future Rheumatology. 2: 139-141. DOI: 10.2217/17460816.2.2.139  1
2006 Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. The Journal of Rheumatology. 33: 2453-7. PMID 17143980  1
2006 Urowitz MB, Ibañez D, Jerome D, Gladman DD. The effect of menopause on disease activity in systemic lupus erythematosus. The Journal of Rheumatology. 33: 2192-8. PMID 16981295  1
2006 Johnson SR, Urowitz MB, Ibañez D, Gladman DD. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. The Journal of Rheumatology. 33: 1990-5. PMID 16924690  1
2006 Prasad R, Ibañez D, Gladman D, Urowitz M. Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus. 15: 285-291. PMID 16761503 DOI: 10.1191/0961203306lu2302oa  1
2006 Urowitz MB, Gladman DD, Ibanez D, Berliner Y. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: A quality improvement study Annals of the Rheumatic Diseases. 65: 115-117. PMID 16344496 DOI: 10.1136/ard.2005.038802  1
2005 Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin P, Gordon C, Barr S, Edworthy S, Bae SC, Petri M, Sibley J, Isenberg D, et al. Race/ethnicity and cancer occurrence in systemic lupus erythematosus. Arthritis and Rheumatism. 53: 781-4. PMID 16208671 DOI: 10.1002/art.21458  0.32
2005 Bernatsky S, Ramsey-Goldman R, Rajan R, Boivin JF, Joseph L, Lachance S, Cournoyer D, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Edworthy S, Barr S, et al. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 64: 1507-9. PMID 16162903 DOI: 10.1136/ard.2004.034504  0.4
2005 Urowitz MB, Feletar M, Bruce IN, Ibañez D, Gladman DD. Prolonged remission in systemic lupus erythematosus. The Journal of Rheumatology. 32: 1467-72. PMID 16078321  0.64
2005 Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheumatic Diseases Clinics of North America. 31: 329-54, vii-viii. PMID 15922149 DOI: 10.1016/j.rdc.2005.01.001  1
2005 Urowitz MB, Gladman DD. Contributions of observational cohort studies in systemic lupus erythematosus: the university of toronto lupus clinic experience. Rheumatic Diseases Clinics of North America. 31: 211-21, v. PMID 15922142 DOI: 10.1016/j.rdc.2005.01.008  1
2005 Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism. 52: 1481-90. PMID 15880596 DOI: 10.1002/art.21029  0.4
2005 Ibañez D, Gladman DD, Urowitz MB. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. The Journal of Rheumatology. 32: 824-7. PMID 15868616  1
2004 Tandon A, Ibañez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis and Rheumatism. 50: 3941-6. PMID 15593212 DOI: 10.1002/art.20638  1
2004 Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmunity Reviews. 3: 418-20. PMID 15351308 DOI: 10.1016/j.autrev.2004.07.003  1
2003 Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis and Rheumatism. 48: 3159-67. PMID 14613278 DOI: 10.1002/art.11296  0.64
2003 Ibañez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. The Journal of Rheumatology. 30: 1977-82. PMID 12966601  1
2003 Gladman DD, Hirani N, Ibañez D, Urowitz MB. Clinically active serologically quiescent systemic lupus erythematosus. The Journal of Rheumatology. 30: 1960-2. PMID 12966598  1
2003 Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. The Journal of Rheumatology. 30: 1955-9. PMID 12966597  1
2003 Feletar M, Ibañez D, Urowitz MB, Gladman DD. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis and Rheumatism. 48: 2067-9. PMID 12847702 DOI: 10.1002/art.11167  1
2003 Brunner HI, Feldman BM, Urowitz MB, Gladman DD. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement. The Journal of Rheumatology. 30: 292-7. PMID 12563683  1
2003 Bruce IN, Gladman DD, Ibañez D, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. The Journal of Rheumatology. 30: 288-91. PMID 12563682  1
2003 Farewell VT, Lawless JF, Gladman DD, Urowitz MB. Tracing studies and analysis of the effect of loss to follow-up on mortality estimation from patient registry data Journal of the Royal Statistical Society. Series C: Applied Statistics. 52: 445-456. DOI: 10.1111/1467-9876.00416  1
2002 Urowitz MB, Kagal A, Rahman P, Gladman DD. Role of specialty care in the management of patients with systemic lupus erythematosus. The Journal of Rheumatology. 29: 1207-10. PMID 12064836  1
2002 Gladman DD, Hussain F, Ibañez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus Lupus. 11: 234-239. PMID 12043887 DOI: 10.1191/0961203302lu170oa  1
2002 Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. The Journal of Rheumatology. 29: 288-91. PMID 11838846  0.64
2001 Urowitz MB. How do I know thee...? Let me count the ways. The varieties of medical evidence Journal of Rheumatology. 28: 2373-2374. PMID 11708404  1
2001 Wallace DJ. Clinical correlates of avascular necrosis in systemic lupus erythematosus. The Journal of Rheumatology. 28: 2365-6. PMID 11669186  1
2001 Rahman P, Gladman DD, Ibanez D, Urowitz MB. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus Lupus. 10: 418-423. PMID 11434577 DOI: 10.1191/096120301678646164  1
2001 Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus Lupus. 10: 93-96. PMID 11237132 DOI: 10.1191/096120301670679959  1
2000 Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherence Arthritis Care and Research. 13: 406-408. PMID 14635317  1
2000 Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB. Vascular events in hypertensive patients with systemic lupus erythematosus Lupus. 9: 672-675. PMID 11199921 DOI: 10.1191/096120300669204787  1
2000 Urowitz M, Gladman D, Bruce I. Atherosclerosis and systemic lupus erythematosus Current Rheumatology Reports. 2: 19-23. PMID 11123035  1
2000 Bruce IN, Burns RJ, Gladman DD, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities Journal of Rheumatology. 27: 2372-2377. PMID 11036832  1
2000 Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with term dependent measures of disease activity Journal of Rheumatology. 27: 1892-1895. PMID 10955329  1
2000 Gladman DD, Koh DR, Urowitz MB, Farewell VT. Lost-to-follow-up study in systemic lupus erythematosus (SLE) Lupus. 9: 363-367. PMID 10878729 DOI: 10.1191/096120300678828325  1
2000 Rahman P, Gladman DD, Urowitz MB. Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use [3] Journal of Rheumatology. 27: 1323-1325. PMID 10813315  1
2000 Urowitz MB, Gladman DD. Accelerated atheroma in lupus - Background Lupus. 9: 161-165. PMID 10805481 DOI: 10.1191/096120300678828271  1
2000 Urowitz MB, Gladman DD. How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology. 39: 238-244. PMID 10788530  1
2000 Zangger P, Gladman DD, Urowitz MB, Bogoch ER. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus Journal of Rheumatology. 27: 919-923. PMID 10782816  1
2000 Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus Journal of Rheumatology. 27: 377-379. PMID 10685800  1
1999 Gladman DD, Urowitz MB. The SLICC/ACR damage index: Progress report and experience in the field Lupus. 8: 632-637. PMID 10568900 DOI: 10.1191/096120399680411335  1
1999 Bruce IN, Urowitz MB, Gladman DD, Hallett DC. Natural history of hypercholesterolemia in systemic lupus erythematosus Journal of Rheumatology. 26: 2137-2143. PMID 10529129  1
1999 Gladman DD, Urowitz MB, Darlington GA. Disease expression and class II HLA antigens in systemic lupus erythematosus Lupus. 8: 466-470. PMID 10483016 DOI: 10.1177/096120339900800610  1
1999 Rahman P, Gladman DD, Urowitz MB. Nasal-septal perforation in systemic lupus erythematosus - Time for a closer look [4] Journal of Rheumatology. 26: 1854-1855. PMID 10451095  1
1999 Urowitz MB, Gladman DD. Evolving spectrum of mortality and morbidity in SLE Lupus. 8: 253-255. PMID 10413200 DOI: 10.1191/096120399678847821  1
1999 Bruce IN, Hallett DC, Gladman DD, Urowitz MB. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy Journal of Rheumatology. 26: 1490-1494. PMID 10405935  1
1998 Urowitz MB, Gladman DD. Measures of disease activity and damage in SLE Bailliere's Clinical Rheumatology. 12: 405-413. PMID 9890104 DOI: 10.1016/S0950-3579(98)80027-7  1
1998 Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus Journal of Rheumatology. 25: 1716-1719. PMID 9733451  1
1998 Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus Journal of Rheumatology. 25: 1526-1530. PMID 9712095  1
1998 Bruce IN, Gladman DD, Urowitz MB. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: A quality improvement study Clinical and Experimental Rheumatology. 16: 435-440. PMID 9706424  1
1998 Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity Journal of Rheumatology. 25: 892-895. PMID 9598886  1
1997 Rahman P, Humphret-Murto S, Gladman DD, Urowitz MB. Cytotoxic therapy in systemic lupus erythematosus: Experience from a single center Medicine. 76: 432-437. PMID 9413429 DOI: 10.1097/00005792-199711000-00006  1
1997 Kreidstein S, Urowitz MB, Gladman DD, Gough J. Hormone replacement therapy in systemic lupus erythematosus Journal of Rheumatology. 24: 2149-2152. PMID 9375875  1
1997 Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus Journal of Rheumatology. 24: 2145-2148. PMID 9375874  1
1997 Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years Journal of Rheumatology. 24: 1061-1065. PMID 9195509  1
1996 Gladman DD, Urowitz MB, Ong A, Gough J, Mackinnon A. Lack of correlation among the 3 outcomes describing SLE: Disease activity, damage and quality of life Clinical and Experimental Rheumatology. 14: 305-308. PMID 8809446  1
1996 Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE) Lupus. 5: 190-195. PMID 8803889 DOI: 10.1177/096120339600500305  1
1996 Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus Arthritis and Rheumatism. 39: 1050-1054. PMID 8651970 DOI: 10.1002/art.1780390625  1
1996 Abu-Shakra M, Urowitz MB, Gladman DD, Ritchie S. The significance of anticardiolipin antibodies in patients with lupus nephritis Lupus. 5: 70-73. PMID 8646230 DOI: 10.1177/096120339600500113  1
1995 Pruzanski W, Urowitz MB, Grouix B, Vadas P. Induction of TNF-α and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis Journal of Rheumatology. 22: 1816-1819. PMID 8991975  1
1995 Combe B, Sany J, Urowitz MB. Extraarterial manifestations during methotrexate therapy for rheumatoid arthritis [1] Journal of Rheumatology. 22: 790. PMID 7791187  1
1995 Urowitz MB. Premature senescence and burden of life--lessons from the rheumatic diseases Journal of Rheumatology. 22: 1007-1008. PMID 7674221  1
1995 Smith MD, Urowitz MB. Accelerated nodulosis, pleural effusion, and pericaridal tamponade during methotrexate therapy [1] Journal of Rheumatology. 22: 1439. PMID 7562795  1
1995 Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality Journal of Rheumatology. 22: 1265-1270. PMID 7562756  1
1995 Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death Journal of Rheumatology. 22: 1259-1264. PMID 7562755  1
1995 Kovacs JAJ, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: A pilot study Journal of Rheumatology. 22: 1247-1253. PMID 7562753  1
1995 Abu-Shakra M, Gladman DD, Urowitz MB, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlations American Journal of Medicine. 99: 624-628. PMID 7503085 DOI: 10.1016/S0002-9343(99)80249-6  1
1994 Walz LeBlanc BAE, Urowitz MB, Gladman DD. Serologically active, clinically quiescent systemic lupus erythematosus - Longterm followup [3] Journal of Rheumatology. 21: 174-175. PMID 8151579  1
1994 Abu-Shakra M, Nicol P, Urowitz MB. Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy Journal of Rheumatology. 21: 934-937. PMID 8064737  1
1994 Walz Leblanc BAE, Dagenais P, Urowitz MB, Gladman DD. Methotrexate in systemic lupus erythematosus Journal of Rheumatology. 21: 836-838. PMID 8064722  1
1994 Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus Journal of Rheumatology. 21: 2064-2067. PMID 7869311  1
1994 Walz LeBlanc BAE, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus predictors of clinical flares Journal of Rheumatology. 21: 2239-2241. PMID 7699623  1
1993 Urowitz MB. Is 'aggressive' therapy necessary for systemic lupus erythematosus? Rheumatic Disease Clinics of North America. 19: 263-270. PMID 8356259  1
1993 Kovacs JAJ, Urowitz MB, Gladman DD. Dilemmas in neuropsychiatric lupus Rheumatic Disease Clinics of North America. 19: 795-814. PMID 8265823  1
1992 Willkens RF, Urowitz MB, Stablein DM, McKendry RJ, Berger RG, Box JH, Fiechtner JJ, Fudman EJ, Hudson NP, Marks CR. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and Rheumatism. 35: 849-56. PMID 1642652 DOI: 10.1002/art.1780350802  1
1992 Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin HA, Bell DA, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, et al. Derivation of the SLEDAI: A disease activity index for lupus patients Arthritis and Rheumatism. 35: 630-640. PMID 1599520 DOI: 10.1002/art.1780350606  1
1992 Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB. Impairment of left ventricular diastolic function in systemic lupus erythematosus. The American Journal of Cardiology. 69: 1629-34. PMID 1598881 DOI: 10.1016/0002-9149(92)90715-B  1
1992 McDonald J, Stewart J, Urowitz MB, Gladman DD. Peripheral vascular disease in patients with systemic lupus erythematosus Annals of the Rheumatic Diseases. 51: 56-60. PMID 1540039 DOI: 10.1136/ard.51.1.56  1
1992 Dagenais P, Urowitz MB, Gladman DD, Norman CS. A family study of the antiphospholipid syndrome associated with other autoimmune diseases Journal of Rheumatology. 19: 1393-1396. PMID 1433007  1
1992 Walz-Leblanc BAE, Urowitz MB, Gladman DD, Hanly PJ. The 'shrinking lungs syndrome' in systemic lupus erythematosus - Improvement with corticosteroid therapy Journal of Rheumatology. 19: 1970-1972. PMID 1294750  1
1992 Gladman DD, Urowitz MB. Assessment of disease activity in lupus Transfusion Science. 13: 129-134. DOI: 10.1016/0955-3886(92)90163-B  1
1991 Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G. Pregnancy outcome following first trimester exposure to chloroquine. American Journal of Perinatology. 8: 174-8. PMID 2029276 DOI: 10.1055/s-2007-999371  1
1991 Gladman DD, Urowitz MB, Doris F, Lewandowski K, Anhorn K. Glucocorticoid receptors in systemic lupus erythematosus Journal of Rheumatology. 18: 681-684. PMID 1865413  1
1990 Urowitz MB, Lee P. The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis Bailliere's Clinical Rheumatology. 4: 193-206. PMID 2032296 DOI: 10.1016/S0950-3579(05)80017-2  1
1989 Ganczarczyk L, Urowitz MB, Gladman DD. "Latent lupus". The Journal of Rheumatology. 16: 475-8. PMID 2746587  1
1989 Langevitz P, Buskila D, Lee P, Urowitz MB. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions. The Journal of Rheumatology. 16: 1433-5. PMID 2600942  1
1988 Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis Arthritis and Rheumatism. 31: 1105-1110. PMID 3422014 DOI: 10.1002/art.1780310904  1
1988 Stafford-Brady FJ, Gladman DD, Urowitz MB. Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulant Archives of Internal Medicine. 148: 1647-1648. PMID 3132903  1
1987 Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus Journal of Rheumatology. 14: 223-226. PMID 3612650  1
1987 Futran J, Shore A, Urowitz MB, Grossman H. Subdural hematoma in systemic lupus erythematosus: Report and review of the literature Journal of Rheumatology. 14: 378-381. PMID 3599010  1
1986 Hanly JG, Urowitz MB. Tendon rupture in systemic lupus erythematosus Annals of the Rheumatic Diseases. 45: 349. PMID 3707223  1
1985 Gertner E, Urowitz MB. Discordance of skin and muscle involvement in dermatomyositis International Journal of Dermatology. 24: 518-519. PMID 4066090  1
1985 Pruzanski W, Vadas P, Stefanski E, Urowitz MB. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme Journal of Rheumatology. 12: 211-216. PMID 4032400  1
1985 Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. The Quarterly Journal of Medicine. 55: 87-98. PMID 4011845 DOI: 10.1093/oxfordjournals.qjmed.a067857  1
1985 Urowitz MB, Rider WD. Myeloproliferative disorders in patients with rheumatoid arthritis treated with total body irradiation The American Journal of Medicine. 78: 60-64. PMID 3881940 DOI: 10.1016/0002-9343(85)90248-7  1
1984 Rubin L, Urowitz MB, Pruzanski W. Systemic lupus erythematosus with paraproteinemia Arthritis and Rheumatism. 27: 638-644. PMID 6610425  1
1984 Urowitz MB, Gladman DD, Tozman ECS, Goldsmith CH. The lupus activity criteria count (LACC) Journal of Rheumatology. 11: 783-787. PMID 6520832  1
1984 Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. The Journal of Rheumatology. 11: 586-7. PMID 6512790  1
1984 Miller MH, Urowitz MB, Gladman DD, Blendis LM. The liver in systemic lupus erythematosus Quarterly Journal of Medicine. 53: 401-409. PMID 6484120  1
1984 Miller MH, Urowitz MB, Gladman DD, Tozman ECS. Chronic Adhesive Lupus Serositis as a Complication of Systemic Lupus Erythematosus: Refractory Chest Pain and Small-Bowel Obstruction Archives of Internal Medicine. 144: 1863-1864. PMID 6477010 DOI: 10.1001/archinte.1984.00350210193033  1
1984 Gladman DD, Urowitz MB. So you suspect mixed connective tissue disease (MCTD). Which tests to perform? International Journal of Dermatology. 23: 392-393. PMID 6384083  1
1984 Ehrenfeld M, Urowitz MB, Platts ME. Selective C4 deficiency, systemic lupus erythematosus and Whipple's disease Annals of the Rheumatic Diseases. 43: 91-94. PMID 6198977  1
1983 Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE--a clinical pathologic study. The Journal of Rheumatology. 10: 973-6. PMID 6663599  1
1983 Gladman DD, Urowitz MB, Tozman EC, Glynn MFX. Haemostatic abnormalities in systemic lupus erythematosus Quarterly Journal of Medicine. 52: 424-433. PMID 6647751  1
1983 Carette S, Urowitz MB. Systemic lupus erythematosus and diffuse soft tissue calcifications International Journal of Dermatology. 22: 416-418. PMID 6629605  1
1983 Miller MH, Urowitz MB, Gladman DD. The significance of thrombocytopenia in systemic lupus erythematosus Arthritis and Rheumatism. 26: 1181-1186. PMID 6626277 DOI: 10.1002/art.1780261002  1
1983 Minta JO, Urowitz MB, Smythe HA, Isenman DE. Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: Aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac Clinical and Experimental Immunology. 53: 555-561. PMID 6616956  1
1983 Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males Medicine (United States). 62: 327-334. PMID 6225928 DOI: 10.1097/00005792-198309000-00005  1
1982 Baron M, Skrinkas G, Hyland R, Urowitz MB. Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma British Heart Journal. 48: 304-305. PMID 7201844  1
1982 Baron M, Skrinskas G, Urowitz MB, Madras PN. Prostaglandin E1 therapy for digital ulcers in scleroderma Canadian Medical Association Journal. 126: 42-45. PMID 7199370  1
1982 Carette S, Urowitz MB, Grosman H, St Louis EL. Cranial computerized tomography in systemic lupus erythematosus Journal of Rheumatology. 9: 855-859. PMID 7161776  1
1982 Urowitz MB. So you suspect systemic lupus erythematosus: Which test to perform? International Journal of Dermatology. 21: 592-593. PMID 7160949  1
1982 Gordon DA, Urowitz MB. Use of azathioprine for rheumatoid arthritis Arthritis and Rheumatism. 25: 1269-1270. PMID 7138599  1
1982 Thorne C, Urowitz MB. Long-term outcome in Felty's syndrome Annals of the Rheumatic Diseases. 41: 486-489. PMID 7125718  1
1982 Thorne C, Urowitz MB, Wanless I, Roberts E, Blendis LM. Liver disease in Felty's syndrome American Journal of Medicine. 73: 35-40. PMID 7091172 DOI: 10.1016/0002-9343(82)90909-3  1
1982 Tozman ECS, Urowitz MB, Gladman DD. Prolonged complete remission in previously severe SLE Annals of the Rheumatic Diseases. 41: 39-40. PMID 7065728 DOI: 10.1136/ard.41.1.39  1
1982 Littlejohn GO, Urowitz MB. Peripheral enthesopathy in diffuse idiopathic skeletal hyperostosis (DISH): A radiologic study Journal of Rheumatology. 9: 568-572. PMID 6813470  1
1982 Littlejohn GO, Baron M, Urowitz MB. Sacroiliac joint abnormalities in calcium pyrophosphate crystal deposition disease Rheumatology International. 1: 195-198. DOI: 10.1007/BF00541176  1
1981 Littlejohn GO, Urowitz MB, Pavlin CJ. Central retinal vein occlusion and scleroderma: Implications for sclerodermatous vascular disease Annals of the Rheumatic Diseases. 40: 96-99. PMID 7469533  1
1981 Littlejohn GO, Urowitz MB, Smythe HA, Keystone EC. Radiographic features of the hand in diffuse idiopathic skeletal hyperostosis (DISH). Comparison with normal subjects and acromegalic patients Radiology. 140: 623-629. PMID 7280223  1
1981 Urowitz MB, Gladman DD, Minta JO. Systemic lupus erythematosus in a patient with C4 deficiency Journal of Rheumatology. 8: 741-746. PMID 6975824  1
1980 Tozman ECS, Urowitz MB, Gladman DD. Systemic lupus erythematosus and pregnancy Journal of Rheumatology. 7: 624-632. PMID 7441654  1
1980 Gladman DD, Urowitz MB. Venous syndromes and pulmonary embolism in systemic lupus erythematosus Annals of the Rheumatic Diseases. 39: 340-343. PMID 7436559  1
1980 Urowitz MB, Gladman DD. Late mortality in SLE--"the price we pay for control" Journal of Rheumatology. 7: 412-416. PMID 7401073  1
1980 Smythe HA, Urowitz MB, Gordon DA. Phillip S. Rosen, M.D., F.R.C.P.(C)--1924-1979 Journal of Rheumatology. 7: 105. PMID 6986467  1
1979 Pruzanski W, Armstrong M, Urowitz MB. Cytotoxic activity of cerebrospinal fluids (CSF's) against lymphocytes and phagocytes: Comparison of normal and systemic lupus erythematosus CSF's Journal of Rheumatology. 6: 259-269. PMID 490521  1
1979 Littlejohn GO, Urowitz MB. Cimetidine, lupus erythematosus, and granulocytopenia Annals of Internal Medicine. 91: 317-318. PMID 464481  1
1979 Tenenbaum J, Urowitz MB, Keystone EC, Dwosh IL, Curtis JE. Leucapheresis in severe rheumatoid arthritis. Annals of the Rheumatic Diseases. 38: 40-4. PMID 434945 DOI: 10.1136/ard.38.1.40  1
1979 Gladman DD, Urowitz MB, Keystone EC. Serologically active clinically quiescent systemic lupus erythematosus. A discordance between clinical and serologic features The American Journal of Medicine. 66: 210-215. PMID 218447 DOI: 10.1016/0002-9343(79)90529-1  1
1978 Urowitz MB, Gladman DD, Chalmers A, Ogryzlo MA. Nail lesions in systemic lupus erythematosus Journal of Rheumatology. 5: 441-447. PMID 739493  1
1978 Pruzanski W, Armstrong M, Urowitz MB. Heterogeneity of cold- and warm-reacting cytotoxins against lymphocytes, granulocytes, and monocytes in rheumatic diseases Clinical Immunology and Immunopathology. 11: 142-156. PMID 737913 DOI: 10.1016/0090-1229(78)90039-9  1
1978 Tan RF, Gladman DD, Urowitz MB, Milne N. Brain scan diagnosis of central nervous system involvement in systemic lupus erythematosus Annals of the Rheumatic Diseases. 37: 357-362. PMID 686868 DOI: 10.1136/ard.37.4.357  1
1978 Chalmers A, Kaprove RE, Reynolds WJ, Urowitz MB. Postdiarrheal arthropathy of Yersinia pseudotuberculosis Canadian Medical Association Journal. 118: 515-516. PMID 343903  1
1978 Gladman DD, Chalmers A, Urowitz MB. Systemic lupus erythematosus with negative LE cells and antinuclear factor Journal of Rheumatology. 5: 142-147. PMID 78982  1
1978 Abel T, Urowitz MB, Smythe HA. Long-term effects of azathioprine in rheumatoid arthritis Arthritis and Rheumatism. 21: 539.  1
1977 Evans JA, Hastings DE, Urowitz MB. The fixed lupus hand deformity and its surgical correction Journal of Rheumatology. 4: 170-175. PMID 881693  1
1977 Urowitz MB. SLE subsets--divide and conquer Journal of Rheumatology. 4: 332-333. PMID 604472  1
1977 Sienknecht CW, Urowitz MB, Pruzanski W, Stein HB. Felty's syndrome. Clinical and serological analysis of 34 cases Annals of the Rheumatic Diseases. 36: 500-507. PMID 596944  1
1977 Gordon DA, Urowitz MB, Smythe HA. The founding editor. Metro A. Ogryzlo, MD., F.R.C.P.(C) Journal of Rheumatology. 4: 1-3. PMID 328877  1
1976 Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA. Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. The Journal of Rheumatology. 3: 295-304. PMID 978665  1
1976 Gladman DD, Gordon DA, Urowitz MB, Levy HL. Pericardial fluid analysis in scleroderma (systemic sclerosis) The American Journal of Medicine. 60: 1064-1068. PMID 937352 DOI: 10.1016/0002-9343(76)90582-9  1
1976 Stein HB, Urowitz MB. Gold-induced enterocolitis. Case report and literature review Journal of Rheumatology. 3: 21-26. PMID 818378  1
1976 Keystone EC, Gladman DD, Urowitz MB, Clarke DA. Mixed leukocyte reaction (MLR) in rheumatoid arthritis: Dose-response kinetics Clinical Immunology and Immunopathology. 5: 320-325. PMID 132318 DOI: 10.1016/0090-1229(76)90040-4  1
1974 Little H, Urowitz MB, Smythe HA, Rosen PS. Asymptomatic spondylodiscitis. An unusual feature of ankylosing spondylitis. Arthritis and Rheumatism. 17: 487-93. PMID 4850683  1
1974 Koehler BE, Urowitz MB, Killinger DW. The systemic effects of intra-articular corticosteroid Journal of Rheumatology. 1: 117-125. PMID 4459468  1
1974 Hunter T, Urowitz MB, Gordon DA. Long term follow up of azathioprine therapy in rheumatoid arthritis Annals of the Royal College of Physicians and Surgeons of Canada. 7: 64.  1
1973 Urowitz MB, Gordon DA, Broder I. Studies into the occurrence of soluble antigen-antibody complexes in disease. V. Second assessment of correlation between the rheumatoid biologically active factor (RBAF) and the clinical features of rheumatoid arthritis Arthritis and Rheumatism. 16: 225-230. PMID 4123762  1
1972 Broder I, Urowitz MB, Gordon DA. Appraisal of rheumatoid arthritis as an immune complex disease Medical Clinics of North America. 56: 529-539. PMID 4111877  1
1971 Urowitz MB, Koehler BE. LUPOID HEPATITIS AND H.A.A The Lancet. 297: 1014-1015. PMID 4102424 DOI: 10.1016/S0140-6736(71)91407-3  1
1968 Mahon WA, Holland J, Urowitz MB. Hyperosmolar, non-ketotic diabetic coma Canadian Medical Association Journal. 99: 1090-1092. PMID 4972381  1
1966 Ogryzlo MA, Urowitz MB, Weber HM, Houpt JB. Effects of allopurinol on gouty and non-gouty uric acid nephropathy Annals of the Rheumatic Diseases. 25: 673-680. PMID 5958697  1
1966 Ogryzlo MA, Urowitz MB, Weber HM, Houpt JB. The treatment of gout and disorders of uric acid metabolism with allopurinol Canadian Medical Association Journal. 95: 1120-1127. PMID 5923471  1
Show low-probability matches.